Apiam Animal Health Limited (ASX:AHX) H1 FY23 Reporting Date and Investor Webinar Notification
Apiam Animal Health Limited (ASX:AHX) will release its financial results for the six months ended 31 December 2022 on Friday 24 February 2023.
Apiam Animal Health Limited (ASX:AHX) will release its financial results for the six months ended 31 December 2022 on Friday 24 February 2023.
Apiam Animal Health Ltd (ASX:AHX) MD Dr. Chris Richards speaks with ABN Newswire on the recent acquisitions the company has made in the mixed animal veterinary industry.
The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 31 December 2022.
Apiam Animal Health Limited (ASX:AHX) is pleased to announce the acquisition of two mixed animal veterinary businesses in strategic NSW regions (the Acquisitions), for total consideration of $11.2 million.
American Medical Association approves CPT PLA code for PromarkerD predictive test for diabetic kidney disease
On 5 April 2022, the Directors of VGI Health Technology Limited (NSX:VTL) announced the sale of its wholly owned subsidiary, Invictus BioPharma Pty Ltd to Invictus BioPharma Holdings Ltd (IVBHL) (the Transaction).
Apiam Animal Health Limited (ASX:AHX) is pleased to announce that it has completed the settlement of Hunter Equine Centre Pty Ltd (Hunter Equine Centre, HEC), a dedicated equine veterinary business located in the Upper Hunter Valley region of NSW.